Involvement of non-protein thiols, mitochondrial dysfunction, reactive oxygen species and p53 in honey-induced apoptosis.
Honey is a complex mixture of different biologically active constituents. Honey possesses anti-inflammatory, antioxidant and antitumor properties. Our chief investigation was to assess the honey induced apoptosis and its molecular mechanism in colon cancer cell growth inhibition. Honey exerted antiproliferative potential against the HCT-15 and HT-29 colon cancer cells as assessed by 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide (MTT) assay. Flow cytometric analysis showed the increasing accumulation of hypodiploid nuclei in the sub-G(1) phase of cell cycle indicating apoptosis. Honey transduced the apoptotic signal via initial depletion of intracellular non protein thiols, consequently reducing the mitochondrial membrane potential (MMP) and increasing the reactive oxygen species (ROS) generation. An increasing earlier lipid layer break was observed in the treated cells compared to the control. Honey induced apoptosis was accompanied by up-regulating the p53 and modulating the expression of pro and anti-apoptotic proteins. Further apoptosis induction was substantiated using DNA fragmentation assay and YO-PRO-1 staining. Results showed honey as a plausible candidate for induction of apoptosis through ROS and mitochondria-dependent mechanisms in colon cancer cells. This will promote honey as a potential chemotherapeutic agent against colon cancer.
Jaganathan
Saravana Kumar
SK
School of Medical Science and Technology, Indian Institute of Technology, Kharagpur, 721 302, West Bengal, India.
Mandal
Mahitosh
M
D017209:Apoptosis; D015153:Blotting, Western; D002453:Cell Cycle; D045744:Cell Line, Tumor; D049109:Cell Proliferation; D048429:Cell Size; D005434:Flow Cytometry; D019073:HT29 Cells; D006722:Honey; D006801:Humans; D008055:Lipids / Q000737:chemistry; D053078:Membrane Potential, Mitochondrial; D008928:Mitochondria / Q000473:pathology*; D017382:Reactive Oxygen Species / Q000378:metabolism*; D013438:Sulfhydryl Compounds / Q000378:metabolism*; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism*
D008055:Lipids; D017382:Reactive Oxygen Species; D013438:Sulfhydryl Compounds; D016159:Tumor Suppressor Protein p53
Biochem Biophys Res Commun. 2004 Dec 24;325(4):1215-22
15555556
Mol Cell Biol. 2003 Dec;23(23):8576-85
14612402
J Biomed Sci. 2000 Jan-Feb;7(1):2-15
10644884
Life Sci. 2001 Sep 7;69(16):1833-50
11693264
Apoptosis. 2007 Jan;12(1):113-23
17136495
Nat Prod Res. 2010 Sep;24(14):1295-306
20803373
J Biol Chem. 1996 Mar 22;271(12):6746-51
8636095
Arch Biochem Biophys. 2000 Feb 15;374(2):142-52
10666292
J Pharmacol Exp Ther. 2001 Jan;296(1):1-6
11123355
Biotechniques. 2001 Jun;30(6):1322-6, 1328, 1330-1
11414226
Cancer Lett. 2004 May 28;208(2):143-53
15142672
Plant Physiol. 2002 Jan;128(1):63-72
11788753
Oncogene. 2000 Jan 13;19(2):307-14
10645010
Cancer Lett. 2006 Nov 8;243(1):80-9
16413113
Int J Urol. 2003 Apr;10(4):213-9
12657101
Vopr Onkol. 1990;36(6):704-9
2378090
Cancer Res. 1993 Sep 15;53(18):4182-8
8364913
Curr Opin Cell Biol. 1995 Jun;7(3):337-43
7662363
J Biomed Biotechnol. 2009;2009:830616
19636435
Biochem Pharmacol. 2003 Dec 15;66(12):2281-9
14637186
Immunol Today. 1994 Jan;15(1):7-10
8136014
Nature. 2000 Oct 12;407(6805):770-6
11048727
Cancer Lett. 2005 Jul 8;225(1):41-52
15922856
Vet Comp Oncol. 2003 Dec;1(4):216-26
19379183
Biofactors. 1998;8(1-2):1-5
9699000
Toxicol Appl Pharmacol. 1997 Apr;143(2):397-406
9144456
Cell Death Differ. 2000 Mar;7(3):314-26
10745276